The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

LONDON BROKER RATINGS: Credit Suisse cuts AstraZeneca and raises GSK

Thu, 15th Sep 2022 09:30

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Friday:

----------

FTSE 100

----------

Credit Suisse cuts AstraZeneca to 'neutral' (outperform) - price target 11,000 pence

----------

Credit Suisse raises GSK to 'neutral' (underperform) - price target 1,430 (1,630) pence

----------

Jefferies cuts Hikma Pharmaceutical price target to 2020 (2290) pence - 'buy'

----------

Berenberg cuts Admiral Group price target to 2,819 (2,903) pence - 'buy'

----------

Berenberg raises InterContinental Hotels target to 6,500 (5,700) pence - 'buy'

----------

Barclays cuts Whitbread price target to 3,500 (4,000) pence - 'overweight'

----------

Berenberg cuts Howden Joinery group price target to 620 (780) pence - 'hold'

----------

RBC cuts Dechra Pharma price target to 4,000 (4,200) pence - 'outperform'

----------

HSBC raises BT Group to 'buy' (hold)

----------

FTSE 250

----------

JPMorgan raises Trainline price target to 425 (420) pence - 'neutral'

----------

Berenberg cuts Volution price target to 460 (550) pence - 'buy'

----------

Berenberg cuts Travis Perkins price target to 910 (1,000) pence - 'hold'

----------

Berenberg cuts Marshalls price target to 380 (400) pence - 'hold'

----------

Berenberg cuts Ibstock price target to 180 (210) pence - 'hold'

----------

Berenberg cuts Genuit price target to 470 (530) pence - 'buy'

----------

Berenberg starts Currys with 'hold' - price target 70 pence

----------

Barclays cuts John Wood Group price target to 250 (320) pence - 'overweight'

----------

Barclays cuts C&C Group price target to 230 (240) pence - 'overweight'

----------

Citigroup raises Tate & Lyle to 'buy' (neutral) - price target 850 pence

----------

Goldman Sachs cuts Marks & Spencer price target to 125 (140) pence - 'sell'

----------

Jefferies cuts Redrow price target to 768 (780) pence - 'buy'

----------

SMALL CAP

----------

Morgan Stanley raises AIB target to 3 (2,80) EUR - 'equal-weight'

----------

Morgan Stanley raises Bank of Ireland target to 7,60 (7,40) EUR - 'equal-weight'

----------

Jefferies cuts DFS Furniture price target to 210 (270) pence - 'buy'

----------

Berenberg cuts Eurocell price target to 250 (310) pence - 'buy'

----------

Berenberg cuts Central Asia Metals price target to 300 (310) pence - 'buy'

----------

Berenberg cuts Forterra price target to 250 (270) pence - 'hold'

----------

Berenberg cuts Breedon price target to 80 (100) pence - 'buy'

----------

Goldman Sachs cuts ITM Power price target to 120 (220) pence - 'sell'

----------

HSBC cuts Johnson Service Group to 'hold' (buy)

----------

Bank of America raises Fevertree Drinks price target to 1,030 (950) pence - 'neutral'

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

Related Shares

More News
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly ...

8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of Engla...

8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4% *

8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the...

8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemi...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.